Six Xarelto Plaintiffs Seek Creation of MDL in Illinois Federal Court
Six plaintiffs in Xarelto lawsuits have requested that similar claims over the blood thinner be centralized in the U.S. District Court, Southern District of Illinois for pretrial proceedings, according to a recent filing.
A motion filed on October 9th with the U.S. Judicial Panel on Multidistrict Litigation (JPML) estimates that cases alleging internal bleeding, pulmonary embolism (PE), deep vein thrombosis (DVT) and other injuries are expected to number “in the thousands,” which necessitates the creation of a multidistrict litigation. Plaintiffs in Xarelto lawsuits allege that the drug’s manufacturers, Johnson & Johnson and Bayer Healthcare Pharmaceuticals, downplay its side effects in promotions that tout its convenience over warfarin, a similar blood thinner that has served as an industry standard for nearly 50 years. Rather than having to undergo routine blood monitoring or adhere to dietary restrictions though, as is common instruction to warfarin users, Xarelto is taken just once a day, orally.
2,000 Reports of Xarelto Internal Bleeding, other Side Effects Filed in 2012
Plaintiffs suggest in their motion that side effects of Xarelto may negate this supposed convenience. More than 1,000 adverse event reports of the medication had been filed with the U.S. Food and Drug Administration (FDA) a year after its approval in 2011, and included 65 instances of patient deaths, they point out. By the end of the following year, 2,000 Xarelto reports had been filed.
The first quarter of 2013 saw 680 complaints, which surpassed those of Pradaxa.
Since Xarelto’s approval in 2011 to prevent strokes in patients with atrial fibrillation and blood clots in those who underwent hip replacement surgery, the number of prescriptions written for the medication has continued to rise. 1 million prescriptions are now written for the blood thinner each year in the U.S., equating to 7 million worldwide.
Xarelto plaintiffs accuse its manufacturer of failing to properly warn that episodes of internal bleeding may be life-threatening since there is no available reversal agent to stop them. As such, use of the medication “could have permanently disabling, life-threatening and fatal consequences.”
Consider a Xarelto Lawsuit
As Xarelto plaintiffs begin to take action in moving forward with their claims, the time is now to take legal action against its manufacturer, and seek compensation for claims over the medication. Call our Firm today at (877) 779-1414.